Guillaume Paré
How do laboratory tools and advances in technology contribute to our understanding of health and disease, including the COVID-19 pandemic?
Join this year’s ‘Omics and Epidemiology virtual conference on May 27 and 28, hosted by
the Population Genomics Program within the Department of Health Research Methods, Evidence, and Impact (HEI) at McMaster University. Registration is free to everyone.
The event will explore the evidence for ‘omics and utility in the health care setting – including COVID-19 and the lungs, depression and gut inflammation, novel platforms in cancer treatment, nutrition, and more.
Zeena Samaan
Co-hosts are Zena Samaan, Department of Psychiatry and Behavioural Neurosciences, and PHRI Senior Scientist Guillaume Paré, Director of the Clinical Research Laboratory and Biobank and Genetic and Molecular Epidemiology Laboratory (CRLB-GMEL), which is is a leading integrated “omics” platform, including proteomics (>1,500 proteins per sample), high-throughput genotyping and DNA sequencing, epigenetics and metabolomics, using advanced analytic and bioinformatics tools including Mendelian randomization and artificial intelligence.
The ‘Omics and Epidemiology virtual conference will include a student research poster competition (with prizes); students are invited to submit an abstract by April 18th.
Visit omicsconference.ca to for full conference details, including the poster competition
guidelines, and to register for free.
